In 2024, Wegovy sales reached $8 billion, while Ozempic, its other Semaglutide product, brought in $17 billion. Lilly’s Mounjaro recorded $11.5 billion in global sales in 2024, an increase of 124% ...

Eli Lilly (LLY) stock in focus as the company launches Mounjaro Kwikpen in India, intensifying competition with Novo ...

In India, home to 74 million diabetes patients, a range of supplements is being marketed as natural GLP-1 alternatives, but ...

Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...

Researchers find programme that could improve IVF outcomes - Women who took part in a weight loss programme had a 21 per cent ...

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...